| Supplier |
Ace Therapeutics |
| Product # |
NSC1087 |
| Pricing |
Inquiry
|
| Product Size |
20 µg
|
| Purity |
≥ 95 % as determined by SDS-PAGE. ≥ 95 % as determined by SEC-HPLC.
|
| Product Type |
Proteins
|
| Synonyms |
FGF-9 Protein, Human; GAF Protein, Human; HBFG-9 Protein, Human; HBGF-9 Protein, Human; SYNS3 Protein, Human
|
| Endotoxin |
< 10 EU per mg of the protein.
|
| Activity |
Measured in a cell proliferation assay using Balb/c 3T3 mouse embryonic fibroblasts. The ED50 for this effect is typically 0.5-5 ng/mL.
|
| Protein Construction |
A DNA sequence encoding the Human FGF9 (NP_002001.1) (Pro3-Ser208) was expressed.
|
| Accession# |
NP_002001.1
|
| Expressed Host |
E. coli
|
| Species |
Human
|
| Predicted N Terminal |
Met
|
| Molecule Mass |
The recombinant Human FGF9 consists of 207 amino acids and predicts a molecular mass of 23.37 kDa.
|
| Formulation |
Lyophilized from sterile PBS, pH 7.4.Please contact us for any concerns or special requirements. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization.
|
| Shipping |
In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature.Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
|
| Stability & Storage |
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
| Reconstitution |
A hardcopy of datasheet with reconstitution instructions is sent along with the products. Please refer to it for detailed information.
|